CORRESP Filing
Kandal M Venture Ltd
Date: June 18, 2025 · CIK: 0002024656 · Accession: 0001213900-25-055492
AI Filing Summary & Sentiment
File numbers found in text: 333-282786
Show Raw Text
CORRESP 1 filename1.htm Dominari Securities LLC 725 Fifth Avenue, 23rd Floor New York, NY 10022 June 18, 2025 VIA EDGAR U.S. Securities & Exchange Commission Office of Life Sciences Division of Corporation Finance 100 F Street, NE Attn: Dale Welcome / Claire Erlanger Re: Kandal M Venture Limited Registration Statement on Form F-1 Initially Filed October 23, 2024, as amended File No. 333-282786 Ladies and Gentlemen: Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the "Act"), the undersigned representative of the underwriters of the offering hereby join in the request of Kandal M Venture Limited (the "Company") that the effective date of the above-referenced Registration Statement be accelerated so as to permit it to become effective at 4:30 p.m., Eastern Time, on June 23, 2025, or as soon thereafter as practicable, or at such other time as the Company or its outside counsel, Loeb & Loeb LLP, requests by telephone that such Registration Statement be declared effective. Pursuant to Rule 460 of the Act, please be advised that there will be distributed to each underwriter or dealer, who is reasonably anticipated to participate in the distribution of the security, as many copies of the proposed form of preliminary prospectus as appears to be reasonable to secure adequate distribution of the preliminary prospectus. The undersigned advises that the several underwriters have complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended. Very truly yours, Dominari Securities LLC as representatives of the several underwriters By: /s/ Eric Newman Name: Eric Newman Title: Executive Vice President, Global Head of Investment Banking